AnaptysBio, Inc. (ANAB) vs Tyra Biosciences, Inc. (TYRA)
- AnaptysBio, Inc. ANAB 45.61 −0.26%
- Tyra Biosciences, Inc. TYRA 19.58 −0.81%
AnaptysBio, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. AnaptysBio, Inc. and Tyra Biosciences, Inc. are of similar size ($1.4B and $1.4B). Tyra Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; AnaptysBio, Inc. trades at 73.6×. AnaptysBio, Inc. has the higher net margin (6.54% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, AnaptysBio, Inc. leads on 8 and Tyra Biosciences, Inc. on 4.
Valuation
Profitability
| Metric | ANAB | TYRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 70.18% |
| Operating margin | 36.14% | 0.00% | 0.00% |
| Net margin | 6.54% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (365.73%) | (34.89%) | (50.72%) |
| Return on assets | 4.76% | (32.99%) | (45.56%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack